King-Jones Heidy 4
4 · Aeglea BioTherapeutics, Inc. · Filed Sep 5, 2023
Insider Transaction Report
Form 4
King-Jones Heidy
See Remarks
Transactions
- Award
Stock Option (Right to Buy)
2023-09-01+13,495,255→ 13,495,255 totalExercise: $0.58Exp: 2033-09-01→ Common Stock (13,495,255 underlying)
Footnotes (1)
- [F1]This option represents the right to purchase 13,495,255 shares of the Issuer's common stock, one quarter of which will vest and become exercisable on September 1, 2024, with the remaining three quarters vesting in monthly installments over the following three years, subject to the Reporting Person's continued employment with the Issuer.